Aspire Biopharma (ASBP) Competitors $0.35 -0.01 (-2.99%) As of 08/5/2025 03:56 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFDA EventsOwnershipSEC FilingsTrendsBuy This Stock ASBP vs. PMVP, ARTV, IMA, CRVO, GNTA, PYXS, ATRA, ASRT, QNTM, and STROShould you be buying Aspire Biopharma stock or one of its competitors? The main competitors of Aspire Biopharma include PMV Pharmaceuticals (PMVP), Artiva Biotherapeutics (ARTV), Ikena Oncology (IMA), CervoMed (CRVO), Genenta Science (GNTA), Pyxis Oncology (PYXS), Atara Biotherapeutics (ATRA), Assertio (ASRT), Quantum Biopharma (QNTM), and Sutro Biopharma (STRO). These companies are all part of the "pharmaceutical products" industry. Aspire Biopharma vs. Its Competitors PMV Pharmaceuticals Artiva Biotherapeutics Ikena Oncology CervoMed Genenta Science Pyxis Oncology Atara Biotherapeutics Assertio Quantum Biopharma Sutro Biopharma Aspire Biopharma (NASDAQ:ASBP) and PMV Pharmaceuticals (NASDAQ:PMVP) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, institutional ownership and earnings. Does the media favor ASBP or PMVP? In the previous week, Aspire Biopharma had 1 more articles in the media than PMV Pharmaceuticals. MarketBeat recorded 1 mentions for Aspire Biopharma and 0 mentions for PMV Pharmaceuticals. Aspire Biopharma's average media sentiment score of 0.00 equaled PMV Pharmaceuticals'average media sentiment score. Company Overall Sentiment Aspire Biopharma Neutral PMV Pharmaceuticals Neutral Do analysts recommend ASBP or PMVP? PMV Pharmaceuticals has a consensus price target of $5.50, indicating a potential upside of 271.62%. Given PMV Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe PMV Pharmaceuticals is more favorable than Aspire Biopharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aspire Biopharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00PMV Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility and risk, ASBP or PMVP? Aspire Biopharma has a beta of 0.79, meaning that its stock price is 21% less volatile than the S&P 500. Comparatively, PMV Pharmaceuticals has a beta of 1.52, meaning that its stock price is 52% more volatile than the S&P 500. Is ASBP or PMVP more profitable? Aspire Biopharma's return on equity of 0.00% beat PMV Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Aspire BiopharmaN/A N/A -508.70% PMV Pharmaceuticals N/A -32.54%-29.59% Which has preferable earnings & valuation, ASBP or PMVP? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAspire BiopharmaN/AN/A-$12.54MN/AN/APMV PharmaceuticalsN/AN/A-$58.71M-$1.18-1.25 Do insiders and institutionals believe in ASBP or PMVP? 19.2% of Aspire Biopharma shares are owned by institutional investors. Comparatively, 90.2% of PMV Pharmaceuticals shares are owned by institutional investors. 48.0% of Aspire Biopharma shares are owned by insiders. Comparatively, 7.6% of PMV Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. SummaryPMV Pharmaceuticals beats Aspire Biopharma on 6 of the 10 factors compared between the two stocks. Get Aspire Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ASBP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ASBP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ASBP vs. The Competition Export to ExcelMetricAspire BiopharmaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$18.06M$3.07B$5.59B$9.53BDividend YieldN/A2.41%4.71%4.14%P/E RatioN/A17.5328.8923.88Price / SalesN/A313.17447.6498.82Price / CashN/A42.6035.6858.35Price / Book-0.167.828.165.60Net Income-$12.54M-$54.52M$3.25B$265.26M7 Day Performance-17.36%2.86%1.12%-0.15%1 Month Performance21.13%17.29%8.22%6.07%1 Year PerformanceN/A13.27%29.12%24.21% Aspire Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ASBPAspire BiopharmaN/A$0.35-3.0%N/AN/A$18.06MN/A0.00N/APMVPPMV Pharmaceuticals2.8279 of 5 stars$1.40-1.4%$5.50+292.9%+1.4%$73.77MN/A-1.1950Positive NewsARTVArtiva Biotherapeutics2.138 of 5 stars$2.83-5.7%$17.80+529.0%-72.3%$73.09M$250K0.0081Upcoming EarningsIMAIkena Oncology3.5038 of 5 stars$17.28-3.5%$35.50+105.4%-15.7%$71.96M$9.16M-2.2570Positive NewsAnalyst RevisionCRVOCervoMed2.8618 of 5 stars$8.83+7.0%$21.50+143.5%-24.6%$71.80M$9.74M-4.054Upcoming EarningsGNTAGenenta Science2.3541 of 5 stars$3.73-3.2%$25.00+571.0%-14.5%$70.35MN/A0.007News CoverageShort Interest ↑PYXSPyxis Oncology2.4716 of 5 stars$1.10-1.8%$9.00+718.2%-66.8%$69.38MN/A-0.6960News CoverageUpcoming EarningsATRAAtara Biotherapeutics3.8342 of 5 stars$11.55+0.3%$20.00+73.2%+37.3%$68.85M$199.73M-3.10330News CoverageUpcoming EarningsGap UpASRTAssertio1.8615 of 5 stars$0.71-0.5%$2.63+268.4%-39.2%$68.58M$124.96M-2.2320News CoverageQNTMQuantum BiopharmaN/A$23.70+1.0%N/AN/A$68.24MN/A-1.48N/ANews CoverageUpcoming EarningsGap DownSTROSutro Biopharma3.8683 of 5 stars$0.81+0.6%$6.11+654.9%-75.2%$68.02M$62.04M-0.27240News CoverageUpcoming Earnings Related Companies and Tools Related Companies PMVP Alternatives ARTV Alternatives IMA Alternatives CRVO Alternatives GNTA Alternatives PYXS Alternatives ATRA Alternatives ASRT Alternatives QNTM Alternatives STRO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ASBP) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredGENIUS Act: Cancel Your Money?They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—no...Priority Gold | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aspire Biopharma Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aspire Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
